SCHEMBL7701818

SCHEMBL7701818

CC1=Nc2cc(S(=O)(=O)O)c3ccccc3c2C1(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
SENP2 Q9HC62 5/20 0.39
SUMO2 P61956 4/20 0.39
SUMO1 P63165 4/20 0.39
SENP7 Q9BQF6 4/20 0.39
SENP1 Q9P0U3 4/20 0.39
SENP3 Q9H4L4 2/20 0.39
MPL P40238 6/20 0.38
TTR P02766 1/20 0.37
RCE1 Q9Y256 1/20 0.36
ATIC P31939 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35
CYP2C19 P33261 1/20 0.35
HIF1A Q16665 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CTRC Q99895 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14566372 0.87 MEN1 (0.55) MEN1KMT2ASENP2SUMO2SUMO1
SCHEMBL136734 0.81 MEN1 (0.44) MEN1KMT2ASENP2SUMO2SUMO1
SCHEMBL14695213 0.80 MEN1 (0.43) MEN1KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL101050 0.77 MEN1 (0.49) MEN1KMT2ASENP2SUMO2SUMO1
SCHEMBL4255042 0.77 MPL (0.40) MEN1KMT2ASENP2SUMO2SUMO1
SCHEMBL4020207 0.77 MEN1 (0.54) MEN1KMT2ATTR
SCHEMBL14958133 0.76 MEN1 (0.52) MEN1KMT2ASENP2SUMO2SUMO1
SCHEMBL4014873 0.76 MEN1 (0.47) MEN1KMT2ASENP2SUMO2SUMO1
SCHEMBL2957950 0.75 MEN1 (0.45) MEN1KMT2A
SCHEMBL135180 0.75 MEN1 (0.36) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576699-B1 NAPHTHOCYANINES FOR USE AS CONTRAST AGENTS PHARMPUR GMBH (DE) 2017-07-12 EP disclosed
US-8835484-B2 Naphthocyanines for use as contrast agents ALAMEDICS GMBH & CO. KG (DE) 2014-09-16 US disclosed
US-20130131354-A1 Naphthocyanines for Use as Contrast Agents AIAMEDICS GmbH & Co. KG (DE) 2013-05-23 US disclosed
EP-2576699-A1 NAPHTHOCYANINES FOR USE AS CONTRAST AGENTS ALAMEDICS GMBH & CO. KG (DE) 2013-04-10 EP disclosed
EP-1165693-A2 SQUARAINE DYES Amersham Pharmacia Biotech UK Limited (GB) 2002-01-02 EP disclosed
WO-2000058405-A2 SQUARAINE DYES AMERSHAM PHARMACIA BIOTECH UK LIMITED (GB) 2000-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131354-A1 Naphthocyanines for Use as Contrast Agents NPM1, UACA, INCENP MEN1 314/4885KMT2A 3765/4885SENP2 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.